Bericht
Intellectual property in the Trans-Pacific Partnership: Increasing the barriers for the access to affordable medicines
Most free trade agreements (FTAs) signed by the United States, the European Union and the members of the European Free Trade Association (EFTA) in the last 15 years contain chapters on intellectual property rights with provisions applicable to pharmaceuticals. Such provisions considerably expand the rights recognized to pharmaceutical companies under the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) established in the context of the World Trade Organization (WTO). The text on intellectual property of the Trans-Pacific Partnership (TPP) goes further than those FTAs. It reflects the ambition of such companies to obtain even higher levels of protection. This paper discusses some characteristics of the TPP negotiations and their main outcomes, and how the adopted TRIPS-plus provisions may negatively affect access to medicines, notably in developing countries that may become parties to that agreement.
- Language
-
Englisch
- Bibliographic citation
-
Series: Research Paper ; No. 62R
- Classification
-
Sozialwissenschaften, Soziologie, Anthropologie
- Subject
-
Immaterialgüterrechte
Arzneimittel
TRIPS
Freihandelsabkommen
USA
EU-Staaten
- Event
-
Geistige Schöpfung
- (who)
-
Correa, Carlos María
- Event
-
Veröffentlichung
- (who)
-
South Centre
- (where)
-
Geneva
- (when)
-
2017
- Handle
- Last update
-
10.03.2025, 11:45 AM CET
Data provider
This object is provided by:
ZBW - Deutsche Zentralbibliothek für Wirtschaftswissenschaften - Leibniz-Informationszentrum Wirtschaft. If you have any questions about the object, please contact the data provider.
ZBW - Deutsche Zentralbibliothek für Wirtschaftswissenschaften - Leibniz-Informationszentrum Wirtschaft. If you have any questions about the object, please contact the data provider.
Object type
- Bericht
Associated
- Correa, Carlos María
- South Centre
Time of origin
- 2017
Other Objects (12)
The international debate on generic medicines of biological origin
Access to medicines and intellectual property: The contribution of the World Health Organization
Regional pooled procurement of medicines in the East African community
Medicines and intellectual property: 10 years of the WHO global strategy
The right to health and medicines: The case of recent negotiations on the global strategy on public health, innovation and intellectual property
The Potential Impacts of Nano-Scale Technologies on Commodity Markets: The Implications for Commodity Dependent Developing Countries
The African Regional Intellectual Property Organization (ARIPO) protocol on patents: Implications for access to medicines
Guidelines on patentability and access to medicines
Transition period for TRIPS implementation for LDCs: Implications for local production of medicines in the East African community
Intellectual property, public health and access to medicines in international organizations
Patent analysis for medicines and biotherapeutics in trials to treat COVID-19
Patent analysis for medicines and biotherapeutics in trials to treat COVID-19
The international debate on generic medicines of biological origin
Access to medicines and intellectual property: The contribution of the World Health Organization
Regional pooled procurement of medicines in the East African community
Medicines and intellectual property: 10 years of the WHO global strategy
The right to health and medicines: The case of recent negotiations on the global strategy on public health, innovation and intellectual property
The Potential Impacts of Nano-Scale Technologies on Commodity Markets: The Implications for Commodity Dependent Developing Countries
The African Regional Intellectual Property Organization (ARIPO) protocol on patents: Implications for access to medicines
Guidelines on patentability and access to medicines
Transition period for TRIPS implementation for LDCs: Implications for local production of medicines in the East African community
Intellectual property, public health and access to medicines in international organizations
Patent analysis for medicines and biotherapeutics in trials to treat COVID-19
Patent analysis for medicines and biotherapeutics in trials to treat COVID-19
The international debate on generic medicines of biological origin
Access to medicines and intellectual property: The contribution of the World Health Organization
Regional pooled procurement of medicines in the East African community
Medicines and intellectual property: 10 years of the WHO global strategy
The right to health and medicines: The case of recent negotiations on the global strategy on public health, innovation and intellectual property
The Potential Impacts of Nano-Scale Technologies on Commodity Markets: The Implications for Commodity Dependent Developing Countries
The African Regional Intellectual Property Organization (ARIPO) protocol on patents: Implications for access to medicines
Guidelines on patentability and access to medicines
Transition period for TRIPS implementation for LDCs: Implications for local production of medicines in the East African community
Intellectual property, public health and access to medicines in international organizations
Patent analysis for medicines and biotherapeutics in trials to treat COVID-19